Brief: Lisata Therapeutics Announces Sponsored Preclinical Research Agreement With The University Of Cincinnati To Study Certepetide For The Treatment Of Endometriosis
28/10/2024 12:55
Oct 28 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES SPONSORED PRECLINICAL
RESEARCH
AGREEMENT WITH THE UNIVERSITY OF CINCINNATI TO STUDY CERTEPETIDE
FOR THE TREATMENT OF ENDOMETRIOSIS
Source text: ID:nGNX96LBgJ
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal